ID: MRFR/HC/2597-HCRR | December, 2017 | Region: Global | 90 pages | Half-Cooked Research Reports
Lactate dehydrogenase test market information: by type (LD1, LD2, LD3, LD4, LD5) by indications (cerebrovascular diseases, liver diseases, blood disorders, others) by equipment (instruments, consumables, others) end users - Global Forecast till 2023
Sources: Mayo Clinic, MRFR Analysis
Lactate dehydrogenase (LDH) is an enzyme occurring in most body tissues such as the liver, heart, pancreas, kidneys, muscles, blood cells etc. that is required for converting sugar into energy. The values of LDH are directly proportional to the disease condition of the body and during diseases the values of LDH increases denoting variety of conditions such as stroke, liver diseases, muscle dystrophy, fatigue etc.
The market for lactate dehydrogenase test is rising due to increasing occurrence of diseases such as cerebrovascular diseases, liver diseases, blood disorders, muscle dystrophy etc. Further fatigue testing due to increase in sports is also an important driver for the lactate dehydrogenase test market.
Considering all these factors the market for lactate dehydrogenase test is expected to reach $ 6.4 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.8 % during 2017-2023.
Figure 1 Global Lactate dehydrogenase test Market, by Indications, 2016 (% Market Share)
The global lactate dehydrogenase test market is segmented on the basis of type, indications, equipment, and end users. Based on type, the market has been segmented as lactate dehydrogenase 1 (LD1), lactate dehydrogenase 2 (LD2), lactate dehydrogenase 3 (LD3), lactate dehydrogenase 4 (LD4), and lactate dehydrogenase 5 (LD5). Based on the indications, the market has been segmented as cerebrovascular diseases, liver diseases, blood disorders, muscle dystrophy and fatigue, necrosis, infections, substance abuse, and others. Based on the equipment, the market has been segmented as instruments (spectroscope, centrifuge, others), consumables and others. Based on the end users, the market has been segmented as hospitals and clinics, diagnostic laboratories, academic and research and others.
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global lactate dehydrogenase test. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.
Key players of Global Lactate dehydrogenase test Market:
Key players profiled in the report are LifeSpan BioSciences, Aviva Systems Biology, Accurex Biomedical Pvt. Ltd., Thermo Fisher Scientific, Bioo Scientific Corporation, Quest Diagnostics, Abcam plc., Randox Laboratories Ltd., Sigma-Aldrich Co. LLC., Merck KGaA and others.
The report for Global Lactate dehydrogenase test Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3. MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
4. MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL LACTATE DEHYDROGENASE TEST MARKET, BY TYPE
5.1 LACTATE DEHYDROGENASE 1 (LD1)
5.2 LACTATE DEHYDROGENASE 2 (LD2)
5.3 LACTATE DEHYDROGENASE 3 (LD3)
5.4 LACTATE DEHYDROGENASE 4 (LD4)
5.5 LACTATE DEHYDROGENASE 5 (LD5)
6. GLOBAL LACTATE DEHYDROGENASE TEST MARKET, BY EQUIPMENT
7. GLOBAL LACTATE DEHYDROGENASE TEST MARKET, BY INDICATIONS
7.1 CEREBROVASCULAR DISEASES
7.2 LIVER DISEASES
7.3 BLOOD DISORDERS
7.4 MUSCLE DYSTROPHY AND FATIGUE, NECROSIS
7.7 SUBSTANCE ABUSE
8. GLOBAL LACTATE DEHYDROGENASE TEST MARKET, BY END USERS
8.1 HOSPITALS AND CLINICS
8.2 DIAGNOSTIC LABORATORIES
8.3 ACADEMIC AND RESEARCH
9. GLOBAL LACTATE DEHYDROGENASE TEST MARKET, BY REGION
9.1 NORTH AMERICA
9.4 MIDDLE EAST & AFRICA
10. COMPETITIVE LANDSCAPE
10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
10.1.1 STRATEGIC PARTNERSHIP
10.1.2 MERGER & ACQUISITION
11. COMPANY PROFILE
11.1 LIFESPAN BIOSCIENCES
11.1.2 PRODUCT OVERVIEW
11.1.4 KEY DEVELOPMENTS
11.2 AVIVA SYSTEMS BIOLOGY
11.2.2 PRODUCT OVERVIEW
11.2.4 KEY DEVELOPMENTS
11.3 ACCUREX BIOMEDICAL PVT. LTD.
11.3.2 PRODUCT OVERVIEW
11.3.4 KEY DEVELOPMENT
11.4 THERMO FISHER SCIENTIFIC
11.4.2 PRODUCT OVERVIEW
11.4.4 KEY DEVELOPMENTS
11.5 BIOO SCIENTIFIC CORPORATION
11.5.2 PRODUCT OVERVIEW
11.5.4 KEY DEVELOPMENTS
11.6 QUEST DIAGNOSTICS
11.6.2 PRODUCT OVERVIEW
11.6.4 KEY DEVELOPMENTS
11.7 ABCAM PLC.
11.7.2 PRODUCT OVERVIEW
11.7.4 KEY DEVELOPMENTS
11.8 RANDOX LABORATORIES LTD.
11.8.2 PRODUCT OVERVIEW
11.8.4 KEY DEVELOPMENTS
11.9 SIGMA-ALDRICH CO. LLC.
11.9.2 PRODUCT OVERVIEW
11.9.4 KEY DEVELOPMENTS
11.10 MERCK KGAA.
11.11.2 PRODUCT OVERVIEW
11.11.4 KEY DEVELOPMENTS
12.1 KEY FINDINGS
12.1.1 FROM CEO’S VIEWPOINT
12.1.2 UNMET NEEDS OF THE MARKET
12.2 KEY COMPANIES TO WATCH
12.3 PREDICTION OF LACTATE DEHYDROGENASE TEST INDUSTRY